Angelo Armandi

57PUBLICATIONS

117CO-AUTHORS

Environmental epidemiologyTe wairua auaha o te Māori (Māori innovation)Medical biochemistry - lipidsMetabolic medicineMedical biotechnology diagnostics (incl. biosensors)

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (57)

Sort by Publication Date:

|Jul 15, 2026

Real-World Safety and Herpes Zoster Outcomes After Recombinant Zoster Vaccination in Inflammatory Bowel Disease.

|May 08, 2026

Editorial: Refining the Natural History of MASLD by Imaging-Based Markers: The GOLDMINE Study.

|Mar 30, 2026

Two-step clinical care pathway to predict MASLD-related advanced fibrosis and long-term outcomes in type 2 diabetes.

Yuping Chen, Bingtian Dong, Xinrui Jin

|Jan 04, 2026

Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment.

Christopher D Byrne, Angelo Armandi, Vanessa Pellegrinelli

|Aug 27, 2025

Author Correction: Μetabolic dysfunction-associated steatotic liver disease: a condition of heterogeneous metabolic risk factors, mechanisms and comorbidities requiring holistic treatment.

Christopher D Byrne, Angelo Armandi, Vanessa Pellegrinelli

|Jul 30, 2025

Thrombospondin-2 is a performant biomarker of at-risk MASH and advanced MASH fibrosis in a large multicentre European cohort.

Vlad Ratziu, Rambabu Surabattula, Elisabetta Bugianesi

Pageof 10

Frequent Collaborators

33 joint publications

Gian Paolo Caviglia

28 joint publications

Chiara Rosso

27 joint publications

Davide Giuseppe Ribaldone

23 joint publications

Giorgio Maria Saracco

22 joint publications

Elisabetta Bugianesi

10 joint publications

Maria Lorena Abate

10 joint publications

Antonella Olivero

8 joint publications

Nuria Perez-Diaz-Del-Campo

6 joint publications

Gabriele Castelnuovo